Comparative studies on the amoebicidal activity of known 5-nitroimidazole derivatives and CG 10213-Go in golden hamsters, Mesocricetus auratus, infected in the liver or caecum or both with trophozoites of Entamoeba histolytica
- 1 June 1983
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 77 (3) , 287-291
- https://doi.org/10.1080/00034983.1983.11811709
Abstract
CG 10213-Go, a 5-nitroimidazole derivative synthesized at the CIBA-Geigy Research Centre, Bombay, proved superior to such currently used 5-nitroimidazole derivatives as metronidazole, ornidazole, secnidazole, tinidazole and nimorazole, against experimental amoebic infections of the liver and caecum in a golden hamster model. CG 10213-Go is now undergoing clinical trials.This publication has 5 references indexed in Scilit:
- Current Status of Chemical CarcinogenesisProceedings of the National Academy of Sciences, 1972
- A simple method of inducing amoebic liver abscess in hamstersPathogens and Global Health, 1966
- Intestinal Amoebiasis Associated with Amoebic Liver Abscess Produced by Intracaecal Inoculation ofEntamoeba Histolyticain HamstersPathogens and Global Health, 1961
- Experimental Amebic Hepatitis in HamstersExperimental Biology and Medicine, 1951
- Some observations on the variation of virulence and response to chemotherapy of strains of entamoeba histolytica in ratsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1951